| |
|
There are five main reasons why computer aided
dosing is so important. |
|
- In the Multi-Centred Randomised Study (Ref, Poller et
al, The Lancet, vol,352 no.9139 pages 1505-1509) Dawn AC achieved 20% to
30% better control in terms of our algorithm (see model two) than
experienced Healthcare Professionals. See Graph
|
 |
-
Experienced medical
staff show natural increased caution in dosing patients at a higher INR range is not shared by the Dawn AC computer software.” (CHEST/119/1/Jan 2000 32S -American College of Chest Physicians).
-
Again, medical staff
caution often means that patients run on the lower end of ranges and
below. The Dawn AC computer system minimises this but at the same
time does not increase the number of INR’s above range This is
particularly so for stabilisation patients i.e. on therapy from week
3 to 22 (See Tables 1 & 2 Below)
-
Computer aided dosing
achieves better levels of control with less dose changes.
This minimises risk as every time a patient changes dose, there is
scope for an error and the wrong dose is taken.( See Table 1 Below).
-
Computer assisted dosing
also allows Standardisation of Care across all healthcare
professional’s managing patients within an organisation.
Standardisation is the first step to improving the whole Quality of
Care. Dawn AC allows you to set your own dosing rules, if required.
We also offer benchmarking to help achieve best practice
Tables extracted from the The Lancet Vol 352 November
1998
Table 1 : For all therapeutic ranges and all sites in a
multi-centred trial, excluding first three weeks of therapy
|
Dawn AC Computer |
Medical Expert |
|
%Time in
Range |
70 |
56 |
|
Mean Visit
Days |
18 |
17 |
|
% Dose
Changes |
38 |
53 |
|
% INRs above
Range |
15 |
17 |
|
% INR’s
Below range |
28 |
33 |
|
Mean INR |
2.6 |
2.6 |
Table 2: Percentage of INR’s Below and Above Range for
stabilisation patients i.e. on therapy from week 3 to 22
|
2.0 to 3.0 range |
|
2.5 to 3.5
range |
|
|
Stabilisation Patients>3 and < 22 weeks |
Below |
Above |
Below |
Above |
|
Dawn AC |
22.8 |
15.7 |
34.5 |
9.1 |
|
Medical
Expert |
32.2 |
16.2 |
44.3 |
19.7 |
Caution from (CHEST/119/1/Jan 2000 32S) :
“It cannot be assumed, however, that all computer
programs will be equally successful, and new programs will require
independent validation by randomised controlled studied to determine
the extent of their ability to accurately predict dosage control”
|
|
|
|
|
|